Microvast Shares Down 12% to $2.04 After Q4 Revenue Miss
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 16 2026
0mins
Should l Buy MVST?
Microvast down 12% at $2.04 after Q4 revenue miss
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MVST?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MVST
About MVST
Microvast Holdings, Inc. provides battery technologies for electric vehicles and energy storage solutions. It is focused on electrification with battery technologies in three core sectors: electric commercial vehicles, energy storage systems (ESS) and battery components. It designs, develops and manufactures high-performance battery solutions for light, medium, and heavy-duty trucks, buses, trains, mining trucks, marine and port vehicles, automated guided vehicles, and specialty vehicles. It offers a range of cell chemistries, including lithium titanate oxide, lithium iron phosphate, nickel manganese cobalt version 1 and nickel manganese cobalt version 2. Its ESS solution captures excess energy from renewable sources and dispatches energy to the grid during peak demand periods. It develops and owns intellectual property and know-how relating to the design, development and manufacture of the four critical components of lithium-ion batteries: cathode, anode, electrolyte and separator.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Microvast Under Investigation Amid Poor Financial Results
- Declining Financial Performance: Microvast reported a revenue of $96.5 million for Q4 2025, representing a 15% year-over-year decline and falling significantly short of the consensus estimate of $136.4 million, indicating mounting pressure in market competition.
- Sharp Margin Decline: The company's gross margin plummeted to approximately 1%, down from about 36% in the same period last year, primarily due to inventory impairment charges, reflecting a severe erosion of profitability.
- Stock Price Crash: Following the earnings report, Microvast's stock price fell by $0.79, or 34.2%, closing at $1.52 per share on March 17, 2026, severely undermining investor confidence.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Microvast and its executives engaged in securities fraud or other unlawful business practices, which could further impact the company's future legal liabilities and reputation.
See More
Ademi LLP Investigates Possible Securities Fraud Claims Against Microvast
- Investigation Background: Ademi LLP is investigating Microvast for possible securities fraud, focusing on potentially false statements regarding its financial statements, business operations, and prospects, indicating possible misconduct in information disclosure.
- Market Impact: The investigation centers on whether Microvast accurately disclosed regulatory shifts in the Korean market and delays in customer platform ramp-up, which could undermine investor confidence in the company's future, negatively impacting its stock price.
- Legal Risks: Should the investigation confirm fraudulent behavior by Microvast, the company may face lawsuits and liability for damages, exacerbating its financial pressures and harming its market reputation.
- Investor Attention: Investors are encouraged to participate in the investigation, reflecting heightened market scrutiny over Microvast's transparency and compliance, which may prompt the company to enhance its information disclosure and compliance management in the future.
See More
Microvast Stock Plummets 22% After Q4 Earnings Miss
- Revenue Decline: Microvast reported Q4 revenue of $96.4 million, a 15% year-over-year decrease, primarily due to regulatory shifts in South Korea and delays in customer platform ramp-up in EMEA, significantly missing the analyst consensus of $136.4 million, indicating serious market challenges.
- Margin Collapse: The Q4 gross margin plummeted to approximately 1%, down from 36% a year earlier, mainly due to inventory impairment charges, highlighting severe issues in cost control and profitability for the company.
- Increased Net Loss: The non-GAAP adjusted net loss per share for Q4 was $0.11, sharply contrasting with market expectations of a $0.02 profit, indicating a continued deterioration in profitability that could undermine investor confidence.
- Uncertain Future Outlook: Although CEO Yang Wu stated that serial production is on track for 2026, Seeking Alpha's Strong Sell rating and a risk score of 1.48 warn investors of high risks regarding Microvast's profitability and market performance, casting doubt on future prospects.
See More
Microvast Reports 15% Revenue Decline in Q4 Amid Regulatory Challenges
- Revenue Decline: Microvast's Q4 revenue fell by 15% to $96.4 million, significantly below the $131.4 million expected by analysts, indicating pressure from regulatory shifts in the South Korean market and delays in customer platform ramp-up in EMEA.
- Widening Loss: The adjusted loss per share widened from $0.01 a year ago to $0.11, representing a 1,000% increase, highlighting the financial challenges the company faces in the current market environment.
- Market Reaction: Despite a 21% drop in premarket trading, retail sentiment on Stocktwits shifted to 'extremely bullish,' with a staggering 1,450% increase in message volume for the ticker, reflecting divergent views among investors regarding the company's future.
- Strategic Focus: Microvast emphasized its commitment to expanding its main battery plant in Huzhou, China, to meet customer demand for current and upcoming cell technologies, indicating that while overall revenue fell short of expectations, the company's fundamentals remain strong.
See More
Microvast Holdings Reports Record Revenue in Q4 2025 Earnings Call
- Revenue Growth: Microvast achieved record annual revenue of $427.5 million in 2025, reflecting a 12.6% year-over-year increase, although slightly below guidance due to regulatory shifts and customer ramp-up delays, underscoring the company's strong market position in battery technology.
- Margin Impact: Despite a $32.5 million inventory impairment charge, the gross margin remained at 28.6%, indicating improvements in product mix and manufacturing efficiencies, which reflect the company's resilience in a competitive market.
- Strategic Expansion: The Huzhou Phase 3.2 expansion is expected to achieve serial production in 2026, aimed at meeting the demand for next-generation battery technology, demonstrating the company's strategic agility in responding to market demand changes.
- Cash Flow Performance: The company reported a net positive operating cash flow of $75.9 million, with total cash and cash equivalents reaching $169.2 million, indicating strong financial health that supports future expansion and investment.
See More
Microvast Holdings Q4 Earnings Analysis
- Disappointing Earnings: Microvast Holdings reported a Q4 non-GAAP EPS of -$0.11, missing expectations by $0.13, indicating ongoing pressure on profitability that may affect investor confidence.
- Revenue and Profit Decline: The company generated $96.4 million in revenue for Q4, falling short of expectations by $34.98 million; however, the record annual revenue of $427.5 million, a 12.6% increase from 2024, suggests potential for long-term growth despite short-term revenue gaps.
- Gross Margin Decline: Gross margin decreased to 28.6% from 31.5% in 2024, primarily due to a $32.5 million inventory impairment charge that negatively impacted margins by 7.6 percentage points, posing challenges to the company's profitability.
- Significant Reduction in Operating Expenses: Operating expenses were $118.3 million, down 50.4% from $238.3 million in 2024, reflecting the company's efforts in cost control; however, a net loss of $29.2 million indicates that further improvements in profitability are necessary.
See More
Microvast Under Investigation Amid Poor Financial Results
- Declining Financial Performance: Microvast reported a revenue of $96.5 million for Q4 2025, representing a 15% year-over-year decline and falling significantly short of the consensus estimate of $136.4 million, indicating mounting pressure in market competition.
- Sharp Margin Decline: The company's gross margin plummeted to approximately 1%, down from about 36% in the same period last year, primarily due to inventory impairment charges, reflecting a severe erosion of profitability.
- Stock Price Crash: Following the earnings report, Microvast's stock price fell by $0.79, or 34.2%, closing at $1.52 per share on March 17, 2026, severely undermining investor confidence.
- Legal Investigation Initiated: Pomerantz LLP is investigating whether Microvast and its executives engaged in securities fraud or other unlawful business practices, which could further impact the company's future legal liabilities and reputation.
See More
Ademi LLP Investigates Possible Securities Fraud Claims Against Microvast
- Investigation Background: Ademi LLP is investigating Microvast for possible securities fraud, focusing on potentially false statements regarding its financial statements, business operations, and prospects, indicating possible misconduct in information disclosure.
- Market Impact: The investigation centers on whether Microvast accurately disclosed regulatory shifts in the Korean market and delays in customer platform ramp-up, which could undermine investor confidence in the company's future, negatively impacting its stock price.
- Legal Risks: Should the investigation confirm fraudulent behavior by Microvast, the company may face lawsuits and liability for damages, exacerbating its financial pressures and harming its market reputation.
- Investor Attention: Investors are encouraged to participate in the investigation, reflecting heightened market scrutiny over Microvast's transparency and compliance, which may prompt the company to enhance its information disclosure and compliance management in the future.
See More
Microvast Stock Plummets 22% After Q4 Earnings Miss
- Revenue Decline: Microvast reported Q4 revenue of $96.4 million, a 15% year-over-year decrease, primarily due to regulatory shifts in South Korea and delays in customer platform ramp-up in EMEA, significantly missing the analyst consensus of $136.4 million, indicating serious market challenges.
- Margin Collapse: The Q4 gross margin plummeted to approximately 1%, down from 36% a year earlier, mainly due to inventory impairment charges, highlighting severe issues in cost control and profitability for the company.
- Increased Net Loss: The non-GAAP adjusted net loss per share for Q4 was $0.11, sharply contrasting with market expectations of a $0.02 profit, indicating a continued deterioration in profitability that could undermine investor confidence.
- Uncertain Future Outlook: Although CEO Yang Wu stated that serial production is on track for 2026, Seeking Alpha's Strong Sell rating and a risk score of 1.48 warn investors of high risks regarding Microvast's profitability and market performance, casting doubt on future prospects.
See More
Microvast Reports 15% Revenue Decline in Q4 Amid Regulatory Challenges
- Revenue Decline: Microvast's Q4 revenue fell by 15% to $96.4 million, significantly below the $131.4 million expected by analysts, indicating pressure from regulatory shifts in the South Korean market and delays in customer platform ramp-up in EMEA.
- Widening Loss: The adjusted loss per share widened from $0.01 a year ago to $0.11, representing a 1,000% increase, highlighting the financial challenges the company faces in the current market environment.
- Market Reaction: Despite a 21% drop in premarket trading, retail sentiment on Stocktwits shifted to 'extremely bullish,' with a staggering 1,450% increase in message volume for the ticker, reflecting divergent views among investors regarding the company's future.
- Strategic Focus: Microvast emphasized its commitment to expanding its main battery plant in Huzhou, China, to meet customer demand for current and upcoming cell technologies, indicating that while overall revenue fell short of expectations, the company's fundamentals remain strong.
See More
Microvast Holdings Reports Record Revenue in Q4 2025 Earnings Call
- Revenue Growth: Microvast achieved record annual revenue of $427.5 million in 2025, reflecting a 12.6% year-over-year increase, although slightly below guidance due to regulatory shifts and customer ramp-up delays, underscoring the company's strong market position in battery technology.
- Margin Impact: Despite a $32.5 million inventory impairment charge, the gross margin remained at 28.6%, indicating improvements in product mix and manufacturing efficiencies, which reflect the company's resilience in a competitive market.
- Strategic Expansion: The Huzhou Phase 3.2 expansion is expected to achieve serial production in 2026, aimed at meeting the demand for next-generation battery technology, demonstrating the company's strategic agility in responding to market demand changes.
- Cash Flow Performance: The company reported a net positive operating cash flow of $75.9 million, with total cash and cash equivalents reaching $169.2 million, indicating strong financial health that supports future expansion and investment.
See More
Microvast Holdings Q4 Earnings Analysis
- Disappointing Earnings: Microvast Holdings reported a Q4 non-GAAP EPS of -$0.11, missing expectations by $0.13, indicating ongoing pressure on profitability that may affect investor confidence.
- Revenue and Profit Decline: The company generated $96.4 million in revenue for Q4, falling short of expectations by $34.98 million; however, the record annual revenue of $427.5 million, a 12.6% increase from 2024, suggests potential for long-term growth despite short-term revenue gaps.
- Gross Margin Decline: Gross margin decreased to 28.6% from 31.5% in 2024, primarily due to a $32.5 million inventory impairment charge that negatively impacted margins by 7.6 percentage points, posing challenges to the company's profitability.
- Significant Reduction in Operating Expenses: Operating expenses were $118.3 million, down 50.4% from $238.3 million in 2024, reflecting the company's efforts in cost control; however, a net loss of $29.2 million indicates that further improvements in profitability are necessary.
See More
